RESUMEN
How a history of influenza virus infections contributes to protection is not fully understood, but such protection might explain the contrasting age distributions of cases of the two lineages of influenza B, B/Victoria and B/Yamagata. Fitting a statistical model to those distributions using surveillance data from New Zealand, we found they could be explained by historical changes in lineage frequencies combined with cross-protection between strains of the same lineage. We found additional protection against B/Yamagata in people for whom it was their first influenza B infection, similar to the immune imprinting observed in influenza A. While the data were not informative about B/Victoria imprinting, B/Yamagata imprinting could explain the fewer B/Yamagata than B/Victoria cases in cohorts born in the 1990s and the bimodal age distribution of B/Yamagata cases. Longitudinal studies can test if these forms of protection inferred from historical data extend to more recent strains and other populations.
Asunto(s)
Virus de la Influenza B/inmunología , Gripe Humana/epidemiología , Gripe Humana/inmunología , Distribución por Edad , Protección Cruzada , Humanos , Memoria Inmunológica , Virus de la Influenza B/clasificación , Gripe Humana/virología , Modelos Estadísticos , Nueva Zelanda/epidemiología , ProbabilidadRESUMEN
Genomic surveillance is an essential part of effective disease control, enabling identification of emerging and expanding strains and monitoring of subsequent interventions. Whole-genome sequencing was used to analyze the genomic diversity of all Neisseria meningitidis isolates submitted to the New Zealand Meningococcal Reference Laboratory during 2013-2018. Of the 347 isolates submitted for whole-genome sequencing, we identified 68 sequence types belonging to 18 clonal complexes (CC). The predominant CC was CC41/44; next in predominance was CC11. Comparison of the 45 New Zealand group W CC11 isolates with worldwide representatives of group W CC11 isolates revealed that the original UK strain, the 2013 UK strain, and a distinctive variant (the 2015 strain) were causing invasive group W meningococcal disease in New Zealand. The 2015 strain also demonstrated increased resistance to penicillin and has been circulating in Canada and several countries in Europe, highlighting that close monitoring is needed to prevent future outbreaks around the world.
Asunto(s)
Infecciones Meningocócicas , Neisseria meningitidis , Canadá , Europa (Continente) , Genómica , Humanos , Nueva Zelanda , SerogrupoRESUMEN
Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.
Asunto(s)
COVID-19/epidemiología , Gripe Humana/epidemiología , Infecciones del Sistema Respiratorio/epidemiología , COVID-19/prevención & control , COVID-19/virología , Control de Enfermedades Transmisibles , Monitoreo Epidemiológico , Hospitalización/estadística & datos numéricos , Humanos , Gripe Humana/prevención & control , Gripe Humana/virología , Nueva Zelanda/epidemiología , Pandemias , Salud Pública , Infecciones del Sistema Respiratorio/prevención & control , Infecciones del Sistema Respiratorio/virología , SARS-CoV-2/aislamiento & purificaciónRESUMEN
Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.
RESUMEN
We compared 2019 influenza seasonality and vaccine effectiveness (VE) in four southern hemisphere countries: Australia, Chile, New Zealand and South Africa. Influenza seasons differed in timing, duration, intensity and predominant circulating viruses. VE estimates were also heterogeneous, with all-ages point estimates ranging from 7-70% (I2: 33%) for A(H1N1)pdm09, 4-57% (I2: 49%) for A(H3N2) and 29-66% (I2: 0%) for B. Caution should be applied when attempting to use southern hemisphere data to predict the northern hemisphere influenza season.
Asunto(s)
Subtipo H1N1 del Virus de la Influenza A/genética , Subtipo H3N2 del Virus de la Influenza A/genética , Virus de la Influenza B/genética , Vacunas contra la Influenza/inmunología , Gripe Humana/prevención & control , Evaluación de Resultado en la Atención de Salud , Vacunación/estadística & datos numéricos , Potencia de la Vacuna , Adolescente , Adulto , Australia/epidemiología , Niño , Chile/epidemiología , Femenino , Humanos , Subtipo H1N1 del Virus de la Influenza A/inmunología , Subtipo H1N1 del Virus de la Influenza A/aislamiento & purificación , Subtipo H3N2 del Virus de la Influenza A/inmunología , Subtipo H3N2 del Virus de la Influenza A/aislamiento & purificación , Virus de la Influenza B/inmunología , Virus de la Influenza B/aislamiento & purificación , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/diagnóstico , Gripe Humana/epidemiología , Gripe Humana/virología , Masculino , Persona de Mediana Edad , Nueva Zelanda/epidemiología , Vigilancia de la Población , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estaciones del Año , Vigilancia de Guardia , Sudáfrica/epidemiologíaRESUMEN
BACKGROUND: Influenza disease burden varies by age and this has important public health implications. We compared the proportional distribution of different influenza virus types within age strata using surveillance data from twenty-nine countries during 1999-2014 (N=358,796 influenza cases). METHODS: For each virus, we calculated a Relative Illness Ratio (defined as the ratio of the percentage of cases in an age group to the percentage of the country population in the same age group) for young children (0-4 years), older children (5-17 years), young adults (18-39 years), older adults (40-64 years), and the elderly (65+ years). We used random-effects meta-analysis models to obtain summary relative illness ratios (sRIRs), and conducted meta-regression and sub-group analyses to explore causes of between-estimates heterogeneity. RESULTS: The influenza virus with highest sRIR was A(H1N1) for young children, B for older children, A(H1N1)pdm2009 for adults, and (A(H3N2) for the elderly. As expected, considering the diverse nature of the national surveillance datasets included in our analysis, between-estimates heterogeneity was high (I2>90%) for most sRIRs. The variations of countries' geographic, demographic and economic characteristics and the proportion of outpatients among reported influenza cases explained only part of the heterogeneity, suggesting that multiple factors were at play. CONCLUSIONS: These results highlight the importance of presenting burden of disease estimates by age group and virus (sub)type.
Asunto(s)
Subtipo H1N1 del Virus de la Influenza A/aislamiento & purificación , Subtipo H3N2 del Virus de la Influenza A/aislamiento & purificación , Gripe Humana/virología , Adolescente , Adulto , Factores de Edad , Anciano , Niño , Preescolar , Bases de Datos Factuales , Femenino , Salud Global , Humanos , Lactante , Recién Nacido , Gripe Humana/diagnóstico , Masculino , Persona de Mediana Edad , Adulto JovenRESUMEN
BACKGROUND: Electronic reporting of Influenza-like illness (eILI) from primary care was implemented and evaluated in three general medical practices in New Zealand during May to September 2015. OBJECTIVE: To measure the uptake of eILI and to identify the system's strength and limitations. METHODS: Analysis of transactional data from the eILI system; comparative study of influenza-like illness cases reported using manual methods and eILI; questionnaire administered to clinical and operational stakeholders. RESULTS: Over the study period 66% of total ILI cases were reported using eILI. Reporting timeliness improved significantly compared to manual reporting with an average of 24 minutes from submission by the clinician to processing in the national database. Users found the system to be user-friendly. CONCLUSION: eILI assists clinicians to report ILI cases to public health authorities within a stipulated time period and is associated with faster, more reliable and improved information transfer.
Asunto(s)
Registros Electrónicos de Salud , Gripe Humana/epidemiología , Vigilancia de Guardia , Registros Electrónicos de Salud/estadística & datos numéricos , Humanos , Nueva Zelanda/epidemiología , Proyectos Piloto , Salud Pública , Factores de TiempoRESUMEN
INTRODUCTION: Determining the optimal time to vaccinate is important for influenza vaccination programmes. Here, we assessed the temporal characteristics of influenza epidemics in the Northern and Southern hemispheres and in the tropics, and discuss their implications for vaccination programmes. METHODS: This was a retrospective analysis of surveillance data between 2000 and 2014 from the Global Influenza B Study database. The seasonal peak of influenza was defined as the week with the most reported cases (overall, A, and B) in the season. The duration of seasonal activity was assessed using the maximum proportion of influenza cases during three consecutive months and the minimum number of months with ≥80% of cases in the season. We also assessed whether co-circulation of A and B virus types affected the duration of influenza epidemics. RESULTS: 212 influenza seasons and 571,907 cases were included from 30 countries. In tropical countries, the seasonal influenza activity lasted longer and the peaks of influenza A and B coincided less frequently than in temperate countries. Temporal characteristics of influenza epidemics were heterogeneous in the tropics, with distinct seasonal epidemics observed only in some countries. Seasons with co-circulation of influenza A and B were longer than influenza A seasons, especially in the tropics. DISCUSSION: Our findings show that influenza seasonality is less well defined in the tropics than in temperate regions. This has important implications for vaccination programmes in these countries. High-quality influenza surveillance systems are needed in the tropics to enable decisions about when to vaccinate.
Asunto(s)
Virus de la Influenza A/inmunología , Virus de la Influenza B/inmunología , Gripe Humana/prevención & control , Vacunación , Humanos , Gripe Humana/epidemiología , Estudios Retrospectivos , Estaciones del Año , Clima TropicalRESUMEN
BACKGROUND: Shiga toxin-producing Escherichia coli (STEC) O157:H7 and related non-O157 STEC strains are enteric pathogens of public health concern worldwide, causing life-threatening diseases. Cattle are considered the principal hosts and have been shown to be a source of infection for both foodborne and environmental outbreaks in humans. The aims of this study were to investigate risk factors associated with sporadic STEC infections in humans in New Zealand and to provide epidemiological information about the source and exposure pathways. METHODS: During a national prospective case-control study from July 2011 to July 2012, any confirmed case of STEC infection notified to regional public health units, together with a random selection of controls intended to be representative of the national demography, were interviewed for risk factor evaluation. Isolates from each case were genotyped using pulsed-field gel electrophoresis (PFGE) and Shiga toxin-encoding bacteriophage insertion (SBI) typing. RESULTS: Questionnaire data from 113 eligible cases and 506 controls were analysed using multivariate logistic regression. Statistically significant animal and environmental risk factors for human STEC infections were identified, notably 'Cattle livestock present in meshblock' (the smallest geographical unit) (odds ratio 1.89, 95% CI 1.04-3.42), 'Contact with animal manure' (OR 2.09, 95% CI 1.12-3.90), and 'Contact with recreational waters' (OR 2.95, 95% CI 1.30-6.70). No food-associated risk factors were identified as sources of STEC infection. E. coli O157:H7 caused 100/113 (88.5%) of clinical STEC infections in this study, and 97/100 isolates were available for molecular analysis. PFGE profiles of isolates revealed three distinctive clusters of genotypes, and these were strongly correlated with SBI type. The variable 'Island of residence' (North or South Island of New Zealand) was significantly associated with PFGE genotype (p = 0.012). CONCLUSIONS: Our findings implicate environmental and animal contact, but not food, as significant exposure pathways for sporadic STEC infections in humans in New Zealand. Risk factors associated with beef and dairy cattle suggest that ruminants are the most important sources of STEC infection. Notably, outbreaks of STEC infections are rare in New Zealand and this further suggests that food is not a significant exposure pathway.
Asunto(s)
Infecciones por Escherichia coli/epidemiología , Escherichia coli Shiga-Toxigénica/genética , Escherichia coli Shiga-Toxigénica/aislamiento & purificación , Adolescente , Adulto , Anciano , Animales , Estudios de Casos y Controles , Bovinos , Niño , Preescolar , Infecciones por Escherichia coli/microbiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nueva Zelanda/epidemiología , Filogenia , Estudios Prospectivos , Escherichia coli Shiga-Toxigénica/clasificación , Adulto Joven , Zoonosis/epidemiología , Zoonosis/microbiologíaRESUMEN
UNLABELLED: INTRODUCTION AND SETTING: Our analysis compares the most comprehensive epidemiologic and virologic surveillance data compiled to date for laboratory-confirmed H1N1pdm patients between 1 April 2009 - 31 January 2010 from five temperate countries in the Southern Hemisphere-Argentina, Australia, Chile, New Zealand, and South Africa. OBJECTIVE: We evaluate transmission dynamics, indicators of severity, and describe the co-circulation of H1N1pdm with seasonal influenza viruses. RESULTS: In the five countries, H1N1pdm became the predominant influenza strain within weeks of initial detection. South Africa was unique, first experiencing a seasonal H3N2 wave, followed by a distinct H1N1pdm wave. Compared with the 2007 and 2008 influenza seasons, the peak of influenza-like illness (ILI) activity in four of the five countries was 3-6 times higher with peak ILI consultation rates ranging from 35/1,000 consultations/week in Australia to 275/100,000 population/week in New Zealand. Transmission was similar in all countries with the reproductive rate ranging from 1.2-1.6. The median age of patients in all countries increased with increasing severity of disease, 4-14% of all hospitalized cases required critical care, and 26-68% of fatal patients were reported to have ≥1 chronic medical condition. Compared with seasonal influenza, there was a notable downward shift in age among severe cases with the highest population-based hospitalization rates among children <5 years old. National population-based mortality rates ranged from 0.8-1.5/100,000. CONCLUSIONS: The difficulty experienced in tracking the progress of the pandemic globally, estimating its severity early on, and comparing information across countries argues for improved routine surveillance and standardization of investigative approaches and data reporting methods.
Asunto(s)
Subtipo H1N1 del Virus de la Influenza A/fisiología , Gripe Humana/epidemiología , Gripe Humana/virología , Pandemias , Australasia/epidemiología , Humanos , Subtipo H1N1 del Virus de la Influenza A/genética , Subtipo H1N1 del Virus de la Influenza A/aislamiento & purificación , Gripe Humana/transmisión , Vigilancia de la Población , Sudáfrica/epidemiología , América del Sur/epidemiologíaRESUMEN
BACKGROUND: The national influenza surveillance in New Zealand is an essential public health component for assessing and implementing strategies to control influenza. OBJECTIVE: The aim of this study is to report the national influenza surveillance data collected during 1997-2006 in terms of the community disease burden, circulating viral strains, hospitalisations, mortality, and immunisation coverage. METHODS: The national influenza surveillance system includes sentinel general practice surveillance, laboratory-based surveillance, and hospital admission and mortality surveillance and immunisation coverage. The results obtained during 1997-2006 were analysed. RESULTS: When the last 10 years were compared to the previous years, sentinel general practice surveillance recorded a decreasing trend of influenza-like illness rates in the community. Sentinel surveillance also showed that children aged 0-4 years were the most affected. Influenza-related hospitalisation surveillance reported an increasing trend of hospital admissions particularly in children aged 0-19 years. Introduction of routine influenza vaccination among the New Zealand elderly was associated with a significant decrease of influenza-related mortality. CONCLUSIONS: This report demonstrates that an integrated virological and epidemiological surveillance system for influenza is essential for monitoring the disease burden, identifying circulating strains, guiding effective vaccination and planning for a potential pandemic.
Asunto(s)
Inmunización/estadística & datos numéricos , Vacunas contra la Influenza/inmunología , Gripe Humana/epidemiología , Gripe Humana/prevención & control , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Gripe Humana/mortalidad , Gripe Humana/virología , Masculino , Persona de Mediana Edad , Nueva Zelanda/epidemiología , Orthomyxoviridae/clasificación , Orthomyxoviridae/aislamiento & purificación , Adulto JovenRESUMEN
AIM: We report the influenza activity in New Zealand in 2005 (including an influenza B epidemic) in terms of the disease burden, hospitalisations, viral strain characterisations, and vaccine recommendations. METHODS: The national influenza surveillance system includes sentinel general practice surveillance, laboratory-based surveillance, and hospital admission and mortality surveillance. The results obtained in 2005 were analysed. RESULTS: During the 2005 winter season, 3929 consultations for influenza-like illness (ILI) were reported from a national sentinel network of 87 general practices. It is estimated that ILI resulting in a visit to a general practitioner affected over 47,108 New Zealanders or about 1.3% of total population. Influenza hospitalisations and viral isolations reached the second highest level in the 15 years from 1990 to 2005. Influenza morbidity (as measured by age specific rates of hospitalisations) was high in children aged 0-19 years. In particular, the burden of influenza in children aged 5-19 years in 2005 was higher than previous years from 1995-2004 as measured by the excess morbidity rate and viral isolations. The ILI consultation rates varied greatly among health districts with the highest rates being reported from the Eastern Bay of Plenty and Otago Health Districts. The influenza activity peaked in the mid of June to July with influenza B activity preceding influenza A activity. This influenza B activity was the highest level recorded over the last 15 years. Influenza B/HongKong/330/2001-like virus was the predominant strain. Significant antigenic drift was observed among the A/Wellington/1/2004 (H3N2)-like viruses and B/HongKong/330/2001-like viruses--resulting in an updated seasonal vaccine strain for 2006. CONCLUSION: The influenza surveillance in 2005 recorded the highest influenza B activity over the last 15 years with co-circulation of influenza B (Hong Kong) and B (Shanghai) strains in an epidemic. The peak of influenza B activity preceded the peak of influenza A activity with significant antigenic drift among the A/Wellington/1/2004 (H3N2)-like viruses and B/HongKong/330/2001-like viruses. Significant excess morbidity was observed in the 5 to 19 year age group in a highly variable geographical distribution across New Zealand. This confirms the value of the national influenza surveillance system as an essential public health component for monitoring the incidence and distribution of influenza and predominant strains in New Zealand.